Transarterial chemoembolization of hepatocellular carcinoma before liver transplantation and risk of post-transplant vascular complications: a multicentre observational cohort and propensity score-matched analysis
- 6 October 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 108 (11) , 1323-1331
Abstract
Background: Transarterial chemoembolization (TACE) in patients with hepatocellular cancer (HCC) on the waiting list for liver transplantation may be associated with an increased risk for hepatic artery complications. The present study aims to assess the risk for, primarily, intraoperative technical hepatic artery problems and, secondarily, postoperative hepatic artery complications encountered in patients who received TACE before liver transplantation. Methods: Available data from HCC liver transplantation recipients across six European centres from January 2007 to December 2018 were analysed in a 1 : 1 propensity score-matched cohort (TACE versus no TACE). Incidences of intraoperative hepatic artery interventions and postoperative hepatic artery complications were compared. Results: Data on postoperative hepatic artery complications were available in all 876 patients (425 patients with TACE and 451 patients without TACE). Fifty-eight (6.6 per cent) patients experienced postoperative hepatic artery complications. In total 253 patients who had undergone TACE could be matched to controls. In the matched cohort TACE was not associated with a composite of hepatic artery complications (OR 1.73, 95 per cent c.i. 0.82 to 3.63, P = 0.149). Data on intraoperative hepatic artery interventions were available in 825 patients (422 patients with TACE and 403 without TACE). Intraoperative hepatic artery interventions were necessary in 69 (8.4 per cent) patients. In the matched cohort TACE was not associated with an increased incidence of intraoperative hepatic artery interventions (OR 0.94, 95 per cent c.i. 0.49 to 1.83, P = 0.870) Conclusion: In otherwise matched patients with HCC intended for liver transplantation, TACE treatment before transplantation was not associated with higher risk of technical vascular issues or hepatic artery complications.Keywords
This publication has 40 references indexed in Scilit:
- Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteriaBritish Journal of Surgery, 2011
- Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomasHepatology, 2011
- Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)Journal of Surgical Oncology, 2010
- Intimal dissection of the hepatic artery following transarterial embolization for hepatocellular carcinoma: An intraoperative problem in adult living donor liver transplantationLiver Transplantation, 2009
- Early Hepatic Artery Thrombosis after Liver Transplantation: A Systematic Review of the Incidence, Outcome and Risk FactorsAmerican Journal of Transplantation, 2009
- Bridging Locoregional Therapy for Hepatocellular Carcinoma Prior to Liver TransplantationAnnals of Surgical Oncology, 2008
- Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk IndexAmerican Journal of Transplantation, 2006
- Hepatic artery thrombosis following orthotopic liver transplantation: A 10-year experience from a single centre in the United KingdomLiver Transplantation, 2005
- Hepatic artery thrombosis after adult liver transplantationLiver Transplantation, 2003
- Peripheral Hepatic Arterial Embolization with Crosslinked Collagen FibersInvestigative Radiology, 1987